Medical devices, healthcare technology and the business of care
510(k) clearance · K260605

Lilium one (USM330)

Lilium Otsuka Co., Ltd. · Decision date Oct 16, 2026

MEDTECHLEDGER EXPLANATIONK260605

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for Lilium one (USM330), a pulsed-echo ultrasonic imaging system, under 510(k) number K260605. The applicant is Lilium Otsuka Co., Ltd. of Sagamihara, Kanagawa, Japan, and the submission was received on 02/24/2026 with a decision date of 10/16/2026. The regulation number is 892.1560, the classification product code is IYO with subsequent product code ITX, and the review panel and medical specialty are both Radiology.

The filing is a Traditional 510(k) reviewed by a third party, and it is not a combination product; no predetermined change control plan was authorized. SESE means the device was cleared as substantially equivalent to a predicate, not approved through the PMA pathway. The source page does not identify the predicate device, describe the device's components or any changed item, or give indications for use, so those details remain unknown from this record.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Oct 16, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260605
Regulatory pathway
510(k) premarket notification
Product code
IYO
Decision code
SESE
Decision date
Oct 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, Imaging, Pulsed Echo, Ultrasonic.

Product code
IYO
FDA device class
2

FDA decision timeline

  1. K260605 received

    Application receipt date recorded by FDA.

  2. K260605 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code IYO

Product / regulatory recordCompanyPathwayDecision dateSource
Evident Vascular, Inc.510(k) clearanceOct 28, 2026FDA
Accuro XVK262093
Rivanna Medical, Inc.510(k) clearanceOct 20, 2026FDA
MEDA Co., Ltd.510(k) clearanceSep 24, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Lilium Otsuka Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Kanagawa

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records